Funding for this research was provided by:
Cancerfonden (Junior Clinical Investigator Award)
Svenska Sällskapet för Medicinsk Forskning (Stora Etableringsanslaget)
Received: 9 September 2019
Accepted: 5 March 2020
First Online: 31 March 2020
Ethics approval and consent to participate
: Ethical approval for studies regarding tumors with neuroendocrine features was acquired by the local ethical review board (Etikprövningsnämnden). Informed consent was obtained from the patient for histological and molecular studies of the excised tumor material, and noted in the patient chart as according to Swedish biobank law. A copy of this consent as outlined in the patient chart is available for review by the Editor-in-Chief of this journal upon request.
: Written informed consent was obtained from the patient’s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.